GE HealthCare Anesthesia Systems Recall
potentially life-threatening risk in Volume Control Ventilation (VCV) modeGE Carestation Anesthesia Systems
GE HealthCare has issued a high-priority correction for certain Carestation anesthesia systems due to a potentially life-threatening risk when used in Volume Control Ventilation (VCV) mode.
Affected Devices
- Carestation 620, 650, 650c
- Carestation 750, 750c
These systems are used in hospitals and surgical settings for delivering anesthesia and ventilatory support to patients of all ages.
The Problem
In VCV mode, the devices affected may fail to ventilate properly. If this happens:
- Alarms and warnings will be triggered (e.g., bellows stop moving, “Unable to Drive Bellows” message, apnea alerts).
- If uncorrected, this can lead to serious injury or death from hypoxia (low oxygen levels).
What to Do
GE HealthCare recommends:
- Do NOT use VCV mode until the device is corrected.
- Use only:
- Pressure Control Ventilation (PCV)
- Pressure Control Ventilation Volume Guarantee (PCV-VG)
- Or manual ventilation
- Perform a Ventilation Screening Test on each system.
- Train your staff and ensure they are aware of the risk and temporary workaround.
- Return the Acknowledgement Form provided in the correction notice.
Questions?
Call GE HealthCare Service at 1-800-437-1171.
If your facility uses these systems, take immediate action to prevent harm. GE HealthCare is currently correcting the devices — no need to remove them from service if alternate modes are used safely.
Abiomed Issues Correction for Automated Impella Controllers
Hardware Updates Required to Address Potential Loss of Hemodynamic Support Abiomed has issued a correction for certain Automated Impella Controllers (AICs) used with the Impella heart pump system after identifying hardware-related issues that could lead to controller...
FDA Clears First OTC Continuous Glucose Monitor for Children
Regulatory Snapshot Device: Stelo® Glucose Biosensor System (Dexcom, Inc.)Indication: Continuous glucose monitoring for individuals ages 2 years and older who do not use insulin, including children with diabetes managed through oral medications and individuals seeking...
FDA Early Alert for Baxter Pressure Breathing Device
FDA Issues Early Alert for Baxter Volara System Patient Circuits Following Therapy Leakage Concerns The U.S. Food and Drug Administration (FDA) has issued an Early Alert regarding a potentially high-risk issue affecting certain Baxter Volara System patient circuits...